Correlation between Hepatic Tumor Blood Flow and Glucose Utilization in a Rabbit Liver Tumor Model

Purpose: To prospectively determine the relationship between hepatic tumor blood flow and glucose utilization in vivo by using a combined positron emission tomographic (PET)/computed tomographic (CT) scanner.

Materials and Methods: The animal care and use subcommittee at the University of Western Ontario approved this study. VX2 carcinoma cells were implanted in the livers of eight male New Zealand white rabbits. Functional CT was performed before tumor implantation and every 4 days thereafter. Each examination consisted of two phases: In the first phase, 30-second cine breath-hold scanning was performed with simultaneous injection of 5 mL of contrast material. In the second phase, 4-second cine scanning was performed without breath holding every 10 seconds for 2 minutes. Second-phase CT images were coregistered with first-phase images to eliminate breathing artifacts. The weighted summation of the aortic and portal venous time-attenuation curves was deconvolved against curves from the liver to derive hepatic blood flow (HBF). Five animals underwent fluorine 18 fluorodeoxyglucose (FDG) scanning before and every 8 days after implantation. FDG uptake was measured as standardized uptake value (SUV). Data were analyzed with repeated-measures analysis of variance and the Tukey-Kramer multiple comparison test. Linear regression was used to compare SUV and HBF in tumors and normal tissue.

Results: In the hypovascular tumor core, (a) mean HBF decreased from 262 mL · min−1 · 100 g−1 ± 22 (standard deviation) at baseline to 101 mL · min−1 · 100 g−1 ± 62 at the end of the study (P < .05) and (b) mean SUV increased from 2.12 g/mL ± 0.06 to 4.56 g/mL ± 0.73 (P < .05) during the same period.

Conclusion: Functional CT in combination with FDG PET can be used to observe changes in HBF and glucose utilization in a growing liver tumor.

© RSNA, 2006

References

  • 1 Johnson PC. Autoregulation of blood flow. Circ Res 1986; 59: 483–495. Crossref, MedlineGoogle Scholar
  • 2 Jones RD, Berne RM. Evidence for a metabolic mechanism in autoregulation of blood flow in skeletal muscle. Circ Res 1965;17:540–554. Crossref, MedlineGoogle Scholar
  • 3 Lehtio K, Oikonen V, Gronroos T, et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. J Nucl Med 2001;42:1643–1652. MedlineGoogle Scholar
  • 4 Mankoff DA, Dunnwald LK, Gralow JR, et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002;43:500–509. MedlineGoogle Scholar
  • 5 McFalls EO, Murad B, Haspel HC, Marx D, Sikora J, Ward HB. Myocardial glucose uptake after dobutamine stress in chronic hibernating swine myocardium. J Nucl Cardiol 2003;10:385–394. Crossref, MedlineGoogle Scholar
  • 6 Sokoloff L. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed Proc 1981;40:2311–2316. MedlineGoogle Scholar
  • 7 Kallinowski F, Schlenger KH, Kloes M, Stohrer M, Vaupel P. Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo. Int J Cancer 1989;44:266–272. Crossref, MedlineGoogle Scholar
  • 8 Brown RS, Fisher SJ, Wahl RL. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med 1993;34:75–82. MedlineGoogle Scholar
  • 9 Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J Nucl Med 1994;35:1067–1075. MedlineGoogle Scholar
  • 10 Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994;13:139–168. Crossref, MedlineGoogle Scholar
  • 11 Lee TY. Functional CT: physiological models. Trends Biotechnol 2002;20(12 suppl):S3–S10. Google Scholar
  • 12 Brix G, Ziegler SI, Bellemann ME, et al. Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply. J Nucl Med 2001;42:1265–1273. MedlineGoogle Scholar
  • 13 Graham MM, Peterson LM, Hayward RM. Comparison of simplified quantitative analyses of FDG uptake. Nucl Med Biol 2000;27:647–655. Crossref, MedlineGoogle Scholar
  • 14 Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974;75:589–596. Google Scholar
  • 15 Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993;188:405–411. LinkGoogle Scholar
  • 16 Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001;176:667–673. Crossref, MedlineGoogle Scholar
  • 17 Richardson PD, Withrington PG. Liver blood flow. I. Intrinsic and nervous control of liver blood flow. Gastroenterology 1981;81:159–173. Google Scholar
  • 18 Schenk WG Jr, McDonald JC, McDonald K, Drapanas T. Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals. Ann Surg 1962;156:463–471. Crossref, MedlineGoogle Scholar
  • 19 Hamacher K, Coenen HH. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. Appl Radiat Isot 2002;57:853–856. Crossref, MedlineGoogle Scholar
  • 20 Johnson JA, Wilson TA. A model for capillary exchange. Am J Physiol 1966;210:1299–1303. Crossref, MedlineGoogle Scholar
  • 21 St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365–1377. Crossref, MedlineGoogle Scholar
  • 22 Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6:731–744. Crossref, MedlineGoogle Scholar
  • 23 Crone C. The permeability of capillaries in various organs as determined by use of the ‘indicator diffusion’ method. Acta Physiol Scand 1963;58:292–305. Crossref, MedlineGoogle Scholar
  • 24 Joseph PM, Ruth C. A method for simultaneous correction of spectrum hardening artifacts in CT images containing both bone and iodine. Med Phys 1997;24:1629–1634. Crossref, MedlineGoogle Scholar
  • 25 Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999;20:63–73. MedlineGoogle Scholar
  • 26 Materne R, Van Beers BE, Smith AM, et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 2000;99:517–525. Crossref, MedlineGoogle Scholar
  • 27 Fukumura D, Yuan F, Monsky WL, Chen Y, Jain RK. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 1997;151:679–688. MedlineGoogle Scholar
  • 28 Folkman J. Tumor angiogenesis. In: Loitta LA, Mendelsohn J, Israel MA, eds. The molecular basis of cancer. Philadelphia, Pa: Saunders, 1995; 206–232. Google Scholar
  • 29 Manz R, Otte J, Thews G, Vaupel P. Relationship between size and oxygenation status of malignant tumors. Adv Exp Med Biol 1983;159:391–398. Crossref, MedlineGoogle Scholar
  • 30 Claffey KP, Brown LF, del Aguila LF, et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996;56:172–181. MedlineGoogle Scholar
  • 31 Weber G. Enzymology of cancer cells. II. N Engl J Med 1977;296:541–551. Crossref, MedlineGoogle Scholar
  • 32 Weber G. Enzymology of cancer cells. I. N Engl J Med 1977;296:486–492. Crossref, MedlineGoogle Scholar
  • 33 Monakhov NK, Neistadt EL, Shavlovskil MM, Shvartsman AL, Neifakh SA. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978;61:27–34. Crossref, MedlineGoogle Scholar
  • 34 Ward-Hartley KA, Jain RK. Effect of glucose and galactose on microcirculatory flow in normal and neoplastic tissues in rabbits. Cancer Res 1987;47:371–377. MedlineGoogle Scholar
  • 35 DiPette DJ, Ward-Hartley KA, Jain RK. Effect of glucose on systemic hemodynamics and blood flow rate in normal and tumor tissues in rats. Cancer Res 1986;46:6299–6304. MedlineGoogle Scholar
  • 36 Vaupel P, Thews G. Pathophysiological aspects of glucose uptake by the tumor tissue under various conditions of oxygen and glucose supply. Adv Exp Med Biol 1976;75:547–553. Crossref, MedlineGoogle Scholar
  • 37 Fukuda K, Taniguchi H, Koh T, Kunishima S, Yamagishi H. Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using 15O and 18F-deoxyglucose. Nucl Med Commun 2004;25:577–583. Crossref, MedlineGoogle Scholar
  • 38 Zasadny KR, Tatsumi M, Wahl RL. FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers. Eur J Nucl Med Mol Imaging 2003;30:274–280. Crossref, MedlineGoogle Scholar
  • 39 Iwata Y, Shiomi S, Sasaki N, et al. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med 2000;14:121–126. Crossref, MedlineGoogle Scholar
  • 40 Cremerius U, Bares R, Weis J, et al. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET. J Nucl Med 1997;38:26–30. MedlineGoogle Scholar
  • 41 Ziegler SI, Haberkorn U, Byrne H, et al. Measurement of liver blood flow using oxygen-15 labeled water and dynamic positron emission tomography: limitations of model description. Eur J Nucl Med 1996;23:169–177. Crossref, MedlineGoogle Scholar
  • 42 Raleigh JA, Dewhirst MW, Thrall DE. Measuring tumor hypoxia. Semin Radiat Oncol 1996;6:37–45. Crossref, MedlineGoogle Scholar
  • 43 Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1–8. Crossref, MedlineGoogle Scholar

Article History

Published in print: June 2006